Company intelligence
Pie Medical Imaging
Solutions in Cardiovascular Analysis | Caas and 3mensio
About Pie Medical Imaging
In the fast-paced world of medical diagnostics and interventions, healthcare professionals face the challenge of obtaining highly accurate advanced image processing solutions. The complexity of medical procedures requires real-time, precise assistance as every decision impacts patient outcomes. At Pie Medical Imaging B.V., we understand the immense pressure on healthcare providers to deliver precise diagnostic and interventional results. The need for advanced image processing solutions is not just a desire but a necessity in modern medicine, enhancing the ability to diagnose, pre-plan, treat, and manage patient care with confidence. With over 30 years of experience in the healthcare sector, we are at the forefront of aiding cardiovascular care with our advanced image analysis software. Our suite of state-of-the-art software solutions, marketed under the brand names Caas and 3mensio, empowers healthcare professionals to achieve their goals and improve patient care. By integrating AI-driven algorithms and user-friendly interfaces, clinicians can: - Enhance Diagnostic Precision: Our powerful software reduces variability and aids in cardiovascular diagnoses, helping to ensure patients receive the right treatment at the right time. - Streamline Clinical Workflows: Our intuitive solutions optimize efficiency, saving valuable time for healthcare professionals and allowing them to focus more on patient care. - Personalize Treatment Planning: Detailed and accurate image analysis aids clinicians in developing tailored treatment strategies, leading to better patient outcomes and satisfaction.
Verified activity
Signals from Pie Medical Imaging
2 published signals
Presence & Recognition
Pie Medical Imaging is hosting a Structural Heart and Interventional Cardiology course on October 7th in Valencia, Spain, alongside Mercé V Electromedicina.
Reported by Pie Medical Imaging
Research & Knowledge
Pie Medical Imaging published a trial of 7,400 patients across 800 locations in Italy and Pakistan, presenting results at the ESC 2026 conference.
Reported by Pie Medical Imaging